SCHEMBL2962923

SCHEMBL2962923

c1ccc2c(-c3cc(-c4cccc5ccccc45)cc(-c4c5ccccc5c(-c5cc(-c6cccc7ccccc67)cc(-c6cccc7ccccc67)c5)c5ccccc45)c3)cccc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FNTA P49354 1/20 0.45
FNTB P49356 1/20 0.45
MCL1 Q07820 2/20 0.45
ACMSD Q8TDX5 1/20 0.45
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA9 Q16790 2/20 0.44
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
KDM4E B2RXH2 2/20 0.43
ALPL P05186 1/20 0.43
GAA P10253 1/20 0.43
POLB P06746 1/20 0.41
ENPP3 O14638 1/20 0.41
ENPP1 P22413 1/20 0.41
ALDH1A1 P00352 4/20 0.41
HSD17B10 Q99714 4/20 0.41
TSHR P16473 3/20 0.41
HPGD P15428 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2958290 0.96 FNTA (0.43) FNTAFNTBMCL1ACMSDCA12
SCHEMBL32106755 0.96 FNTA (0.43) FNTAFNTBMCL1ACMSDCA12
SCHEMBL2010178 0.91 CA12 (0.50) FNTAFNTBMCL1ACMSDCA12
SCHEMBL29866205 0.91 CA12 (0.50) FNTAFNTBMCL1ACMSDCA12
SCHEMBL20622904 0.91 HDAC8 (0.41) FNTAFNTBMCL1ACMSDCA12
SCHEMBL2954967 0.89 PIM1 (0.45) FNTAFNTBMCL1ACMSDCA12
SCHEMBL32106752 0.89 PIM1 (0.45) FNTAFNTBMCL1ACMSDCA12
SCHEMBL26750850 0.88 FNTA (0.38) FNTAFNTBMCL1ACMSDCA12
SCHEMBL24618763 0.86 MCL1 (0.49) MCL1ACMSDCA12CA1CA2
SCHEMBL30150715 0.86 MCL1 (0.45) FNTAFNTBMCL1ACMSDCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100025661-A1 Luminescent material and organic electroluminescent device using the same JNC CORPORATION (JP) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100025661-A1 Luminescent material and organic electroluminescent device using the same TRPV3, TRPC3, HVCN1 FNTA 3087/4885FNTB 3312/4885MCL1 3588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.